Steward Partners Investment Advisory’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6K Hold
100
﹤0.01% 3318
2025
Q4
$15.9K Hold
100
﹤0.01% 3234
2025
Q3
$9.36K Buy
+100
New +$7.07K ﹤0.01% 3429

Other funds holding LABU

Steward Partners Investment Advisory's LABU Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q1 2026 at 100 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3318.

Steward Partners Investment Advisory first reported a position in LABU in Q3 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Steward Partners Investment Advisory held 100 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $16.6K as of Q1 2026.
  • Steward Partners Investment Advisory left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3318 holding.
  • Steward Partners Investment Advisory first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.